Red Cell Distribution Width Upon Hospital Admission Predicts Short-Term Mortality in Hospitalized Patients With

Christoph C Kaufmann1, Amro Ahmed1, Ulrich Brunner1

  • 1Third Medical Department With Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria.

Frontiers in Medicine
|April 5, 2021
PubMed

Insights

Red cell distribution width (RDW) is a significant predictor of short-term mortality in COVID-19 patients. Higher RDW levels on admission indicate increased risk, independent of other factors, aiding in prognosis.

Area of Science:

  • Medical Science
  • Clinical Medicine
  • Hematology

Background:

  • Coronavirus disease (COVID-19) emerged in late 2019 and rapidly became a global pandemic.
  • Red cell distribution width (RDW) is recognized as a prognostic indicator in various medical conditions.
  • Emerging evidence suggests RDW may also hold prognostic value in COVID-19 patients.

Purpose of the Study:

  • To investigate the prognostic value of Red cell distribution width (RDW) in predicting 28-day mortality in patients diagnosed with COVID-19.
  • To assess whether RDW levels on admission can serve as an independent predictor of short-term mortality in COVID-19.

Main Methods:

  • A retrospective, observational study was conducted with 423 consecutive COVID-19 patients admitted between March 12, 2020, and December 4, 2020.
  • Red cell distribution width (RDW) levels were collected upon patient admission.
  • Statistical analyses were performed to evaluate the predictive value of RDW for 28-day mortality, including adjustment for confounders.

Main Results:

  • A total of 423 patients were analyzed, with a 28-day mortality rate of 15.4% (65 deaths).
  • Median RDW levels were significantly higher in non-survivors compared to survivors (14.6% vs. 13.4%, P < 0.001).
  • Elevated RDW independently predicted 28-day mortality (adjusted OR 1.368, P = 0.002), even after accounting for clinical factors and comorbidities.

Conclusions:

  • Red cell distribution width (RDW) is a significant and independent prognostic marker for short-term mortality in COVID-19 patients.
  • RDW levels measured on admission can aid in assessing the risk of mortality in COVID-19.
  • The prognostic utility of RDW in COVID-19 is consistent and independent of established risk factors.

Related Concept Videos